Health
Surface testing for SARS-CoV2 in hematology/oncology settings reveals negligible detection – EurekAlert
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency…
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces…
-
General14 hours agoWoman in her 20s dies after dog attack in Western Australia’s north
-
General21 hours agoGold Coast warned it faces traffic gridlock without major shift to public transport
-
Noosa News23 hours agoDicky Bill salad greens farms enter administration with 180 job cuts just before Christmas
-
Noosa News13 hours agoLuxury caravan manufacturer Zone RV collapses into administration